Suven Life Sciences P/E Ratio
Suven Life Sciences (SUVEN) P/E ratio is not applicable — EPS (TTM) ₹-12.13, 8 consecutive loss quarters. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company has been reporting losses for 8 consecutive quarters. P/E ratio cannot be calculated for loss-making companies.
Consecutive Loss Quarters: 8
Current EPS: ₹-12.13
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Mar 2026 | -2.02 | -46 | Loss |
| Sept 2025 | -3.48 | -77 | Loss |
| Mar 2025 | -2.02 | -44 | Loss |
| Jun 2025 | -2.36 | -52 | Loss |
| Dec 2025 | -4.55 | -102 | Loss |
| Sept 2024 | -2.27 | -50 | Loss |
| Mar 2024 | -1.22 | -27 | Loss |
| Jun 2024 | -1.29 | -28 | Loss |
Healthcare Peers with Valid P/E Ratios — SUVEN Comparison
Healthcare sector average P/E 55.63, median 31.4 — SUVEN excluded (negative EPS).
Sector Average PE
55.63
Sector Median PE
31.4
Lowest PE
2.86
Profitable Companies
195
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.61 | ₹64 | Low |
| Sunrest Lifescience | SUNREST | 3.76 | ₹30 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.76 | ₹7,399 | Low |
| Shelter Pharma | SHELTER | 5.23 | ₹47 | Low |
| Dipna Pharmachem | DPL | 5.39 | ₹14 | Low |
| JFL Life Sciences | JFLLIFE | 5.41 | ₹68 | Low |
| Amwill Health Care | AMWILL | 7.26 | ₹83 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹84 | Low |
| Galaxy Medicare | GML | 7.8 | ₹27 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see Suven Life Sciences share price screener.
- Read Suven Life Sciences dividend policy for the complete payout history and dividend yield track record.
- See SUVEN book value to compare market price against book value per share.